Keywords: prostatic neoplasms; photochemotherapy; WST11 compound; therapeutic occlusion; treatment outcome; AS; active surveillance; CSC; clinically significant cancer; FT; focal therapy; HIFU; high intensity focused ultrasound; IIEF; International Index of Erectil
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: DBS; Deep brain stimulation; ET; Essential tremor; PSA; Posterior subthalamic area; PSM; Probabilistic stimulation map; VIM; Ventral intermediate nucleus; VNA; Volume of neural activation; ZI; Zona incerta; Deep brain stimulation; Essential tremor; Probab
Keywords: prostatic neoplasms; testosterone; prostate-specific antigen; leuprolide; mortality; ADT; androgen deprivation therapy; CAD; continuous androgen deprivation; CRPC; castration resistant prostate cancer; CSS; cause specific survival; IAD; intermittent andro
Keywords: prostatic neoplasms; biopsy; iatrogenic disease; infection; complications; BPH; benign prostatic hyperplasia; PNBx; prostate needle biopsy; PSA; prostate specific antigen; SPARCS; New York Statewide Planning and Research Cooperative System; USPSTF; United
Keywords: prostatic neoplasms; biomarkers; cancer; biopsy; neoplasm recurrence; local; watchful waiting; BCR; biochemical relapse; CHUM; Centre hospitalier de l'Université de Montréal; NCCN®; National Comprehensive Cancer Network®; PSA; prostate specific anti
Keywords: prostatic neoplasms; biopsy; magnetic resonance imaging; diagnostic imaging; standards; CCF; Cleveland Clinic Foundation; DCE; dynamic contrast enhanced T1-weighted imaging; DWI; diffusion-weighted imaging; GG; grade group; JHH; Johns Hopkins Hospital; mp
Keywords: prostatic neoplasms; SEER program; watchful waiting; prostate-specific antigen; AS; active surveillance; DT; definitive therapy; EM; expectant management; PCa; prostate cancer; PSA; prostate specific antigen; T-stage; tumor stage; U.S.; United States;
Keywords: IBD; inflammatory bowel diseases; GI tract; gastrointestinal tract; UC; ulcerative colitis; CD; Crohn's disease; GWAS; genome-wide association study; SNP; single-nucleotide polymorphism; NADPH; nicotinamide adenine dinucleotide phosphate; MDP; muramyl dip
Keywords: prostatic hyperplasia; arteries; embolization; therapeutic; treatment outcome; therapies; investigational; AUR; acute urinary retention; BPH; benign prostatic hyperplasia; CT; clinical trial; IIEF; International Index of Erectile Function; ITT; intent to
Keywords: cardiovascular pseudoaneurysm; outcomes; surgery; AV; aortic valve; CV; cardiovascular; euroSCORE; European System for Cardiac Operative Risk Evaluation; HR; hazard ratio; LV; left ventricular; PSA; pseudoaneurysm;
Keywords: prostatectomy; prostate-specific antigen; monitoring; physiologic; follow-up studies; recurrence; BCR; biochemical recurrence; PSA; prostate specific antigen; PSA-DT; PSA doubling time;
Keywords: prostatectomy; robotic surgical procedures; comparative effectiveness research; propensity score; ADT; androgen deprivation therapy; ORP; open radical prostatectomy; PCa; prostate cancer; PSA; prostate specific antigen; RARP; robot-assisted radical prosta
Keywords: ACN; acetonitrile; APs; alkylphenols; APxEOs; alkylphenol ethoxylates; C18; octadecylsilyl; d-SPE; dispersive-solid phase extraction; EO; ethoxylate; ESI; electrospray ionization; GCB; graphitized carbon black; LOD; limit of detection; LOQ; limit of quant
Keywords: Piperazine derivatives; MTT assay; α1A blocking activity; Pharmacokinetics; BPH; Benign prostatic hyperplasia; T; testosterone; DHT; dihydrotestosterone; SARM; selective androgen receptor modulator; PSA; prostate specific antigen; MTT; 3-(4, 5-dimethylth
Keywords: AA; Ascorbic Acid; Ab; Antibody; AFM; Atomic Force Microscopy; AFP; α-Fetoprotein; AgNPs; Silver Nanoparticles; APTES; 3-Aminopropyltriethoxysilane; AuNCs; Gold Nanocubes; AuNPs; Gold Nanoparticles; BN; Boron Nitride; BNS; Boron Nitride Nanosheets; BSA;
Keywords: polymeric drug delivery system; transdermal; crystallization; amorphous; physical stability; thermal analysis; hydration; water sorption; thermodynamics; mathematical model; a; activity; API; active pharmaceutical ingredient; ASA; acetylsalicylic acid; DI
Keywords: prostatic neoplasms; prostatectomy; neoplasm staging; mortality; prostate-specific antigen; AJCC; American Joint Committee on Cancer; BCR; biochemical recurrence; bRFS; biochemical recurrence-free survival; CSS; cancer specific survival; GG; Grade Group;
Keywords: BLSS; biotechnical Life Support System; DLI; daily light integral; DNA; deoxyribonucleic acid; ESM; Equivalent System Mass; ETC; electron transport chain; ISS; International Space Station; LAI; leaf area index; LED; light-emitting diode; LSC; Life Cycle C
Keywords: Ag@MSN; silver hybridized mesoporous silica nanoparticles; AFP; alpha-fetoprotein; APBA; 3-aminophenylboroic acid; APTES; 3-aminopropyltriethoxysilane; APTMS; aldehyde propyltrimethoxysilane; AuNPs@GMCs; graphitized mesoporous carbon-gold nanoparticles; B
Keywords: AD; atopic dermatitis; α2HS-GP; alpha-2-HS-glycoprotein; CCL20; C-C motif ligand 20; CCR2; C-C chemokine receptor type 2; CRP; C-reactive protein; CYA; ciclosporin; DC; dendritic cells; Dkk-1; dickkopf-related protein 1; dMVECs; dermal microvascular
Keywords: ADT; androgen deprivation therapy; AR; androgen receptor; ASO; antisense oligonucleotide; CARN; castration-resistant Nkx3.1 expressing cells; CK; cytokeratin; CRPC; castration-resistant prostate cancer; DMBA; 7,12-dimethylbenz[a]anthracene; ECM; extracell
Polybrominated diphenyl ethers and metabolites - An analytical review on seafood occurrence
Keywords: Brominated flame retardants; Polybrominated diphenyl ethers; Metabolites; Seafood; Contaminants; Chemical analysis; Food safety; ACS; American Chemical Society; APCI; atmospheric pressure chemical ionization; BFR; brominated flame retardant; CCG; chemical
Keywords: EV(s); extracellular vesicle(s); MV(s); microvesicle(s); AB(s); apoptotic bodie(s); TME; tumor microenvironment; TfRs; transferrin receptors; MVE; multivesicular endosomes; MHC; major histocompatibility complex; miRNAs; microRNAs; PCa; prostate cancer; ES
Keywords: ATR; Autothermal reforming; CFBMMR; Cascading fluidized-bed membrane methanol reactor; CMR; Catalytic membrane reactor; CR; Conventional Reactor; CVD; Chemical vapor deposition; Da; Damkohler number; DME; Dimethyl ether; DR; Dry reforming; EAR; Ethanol au
Keywords: empiric antibiotics; prostate biopsy; prostate cancer; PSA;
Keywords: prostatic neoplasms; diagnosis; biopsy; depression; anxiety; PCa; prostate cancer/carcinoma; PSA; prostate specific antigen; TRPB; transrectal prostate biopsy;
Keywords: cost-effectiveness; modeling; PHI; prostate cancer; PSA; screening;
Keywords: prostatic neoplasms; neoplasm grading; prostate-specific antigen; continental population groups; BMI; body mass index; NCCN®; National Comprehensive Cancer Network®; PCa; prostate cancer; PSA; prostate specific antigen; PSAD; PSA density; PSAM; PSA mass
Keywords: BMI; body mass index; CRP; C-reactive protein; PSA; prostate-specific antigen; HDL; High-density lipoprotein; Metabolic syndrome; Obesity; Cancer; Overweight; Breast cancer;
Keywords: Prostate cancer; PSA; Salvage radiotherapy; Prostatectomy;
Keywords: CAC; Ottawa Regional Prostate Cancer Assessment Center; DRE; digital rectal examination; PSA; prostate-specific antigen; RR; relative risk;
Keywords: recurrence; prostate-specific antigen; prostatectomy; BCR; biochemical recurrence; CaP; prostate cancer; PSA; prostate specific antigen; RP; radical prostatectomy; SP; systemic progression;
Keywords: Bronchiectasis; Lung transplantation; Survival; Bronchiolitis obliterans syndrome; Pseudomonas aeruginosa; Chronic airway infection; ABPA; Allergic bronchopulmonary aspergillosis; AMR; Antibody-mediated rejection; BAL; Bronchoalveolar lavage; BMI; Body ma
Keywords: Cancer biomarker; Electrochemical immunosensor; Poly(N-isopropylacrylamide); PSA; CA125; CEA;
Keywords: prostatic hyperplasia; laser therapy; volatilization; ambulatory surgical procedures; anesthesia; local; BPH; benign prostatic hyperplasia; ED; erectile dysfunction; KTP; potassium titanyl phosphate; OAB; overactive bladder; PSA; prostate specific antigen
Keywords: AMAA; N-acetylmuramoyl-l-alanine amidase; COMP; cartilage oligomeric matrix protein; C3; complement factor C3; CK17; cytokeratin17; DSP; desmoplakin; HP; haptoglobin; JUP; junction plakoglobin; KLK8; kallikrein-8; KLKB1; plasma kallikrein; PIGR; polymeric
Keywords: Hydrogen networks; Purifier models; Membrane; PSA; Pressure ratio
Keywords: PSA; TRUS; Prostatic; Carcinoma; Treatment; Antigène spécifique de la prostate; Ãchographie; Traitement; Adénocarcinome prostatique;
Keywords: prostate-specific antigen; prostatic neoplasms; recurrence; prostatectomy; BCR; biochemical recurrence; LOQ; limit of quantitation; PSA; prostate specific antigen; RP; radical prostatectomy;
Keywords: prostatic neoplasms; SEER program; United States/epidemiology; watchful waiting; early detection of cancer; BLS; Bureau of Labor Statistics; CM; conservative management; CPI; Consumer Price Index; NCCN®; National Comprehensive Cancer Network®; PCa; pros
Keywords: Choline; Methyl; Prostate cancer; Sphingomyelin; Statin; BPH; benign prostatic hyperplasia; DMG; dimethylglycine; LDL; low density lipoproteins; Lyso-PtdCho; lysophosphatidylcholine; PCa; prostate cancer; PtdCho; phosphatidylcholine; PtdEth; phosphatidyle
Keywords: Pca; prostate cancer; mpMRI; multiparametric magnetic resonance imaging; EBRT; external beam radiation therapy; DRE; digital rectal examination; TRUS; transrectal ultrasonography; PSA; prostate-specific antigen; GS; Gleason score; NCCN; National comprehen
Keywords: Prostate cancer; Biochemical response; Androgen deprivation; PSA; Radiotherapy;
Keywords: Cancer incidence; ERSPC; Prostate cancer; PSA; Screening;
Keywords: PCa; prostate cancer; PSA; prostate screening antigen; DRE; digital rectal exam; OR; odds ratio; CI; confidence interval; Prostate cancer; Alcohol; Etiology; Case-control;
Keywords: Men's health; prostate cancer; PSA; urology;
Keywords: prostatic neoplasms; genomics; biological assay; prostatectomy; watchful waiting; AP; adverse pathology; AS; active surveillance; CAPRA; Cancer of the Prostate Risk Assessment; GPS; Genomic Prostate Score; LFP; likelihood of favorable pathology; LIR; low
Keywords: AUR; acute urinary retention; BPH; benign prostatic hyperplasia; CI; confidence interval; DSA; Digital subtraction angiography; IIEF; International Index of Erectile Function; IPSS; International Prostate Symptom Score; LUTS; lower urinary tract symptoms;
Keywords: High-risk prostate cancer; PSA; Survival; NCDB;
Keywords: BPH; benign prostatic hyperplasia; IPSS; International Prostate Symptom Score; IRB; institutional review board; LUTS; lower urinary tract symptom; MeSH; Medical Subject Headings; PAE; prostatic artery embolization; PSA; prostate-specific antigen; PVR; pos